share_log

19,928 Shares in Semler Scientific, Inc. (OTCMKTS:SMLR) Acquired by Walleye Capital LLC

19,928 Shares in Semler Scientific, Inc. (OTCMKTS:SMLR) Acquired by Walleye Capital LLC

Walleye Capital LLC收購Semler Science,Inc.(場外交易代碼:SMLR)的19,928股股份
Defense World ·  2022/09/20 04:11

Walleye Capital LLC bought a new position in shares of Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 19,928 shares of the medical equipment provider's stock, valued at approximately $988,000.

根據Walleye Capital LLC最近提交給美國證券交易委員會(Securities And Exchange Commission)的文件,該公司在第一季度購買了Semler Science,Inc.(場外交易市場代碼:SMLR-GET Rating)的新股票頭寸。該公司購買了這家醫療設備供應商的19,928股股票,價值約為98.8萬美元。

Several other hedge funds have also added to or reduced their stakes in the business. Nantahala Capital Management LLC boosted its position in Semler Scientific by 27.9% during the 1st quarter. Nantahala Capital Management LLC now owns 356,875 shares of the medical equipment provider's stock worth $17,687,000 after buying an additional 77,790 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Semler Scientific by 49.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 227,529 shares of the medical equipment provider's stock worth $11,276,000 after purchasing an additional 75,574 shares during the period. EVR Research LP acquired a new position in shares of Semler Scientific in the 1st quarter worth approximately $9,912,000. Avalon Investment & Advisory lifted its position in shares of Semler Scientific by 244.0% in the 1st quarter. Avalon Investment & Advisory now owns 157,534 shares of the medical equipment provider's stock worth $7,807,000 after purchasing an additional 111,743 shares during the period. Finally, Wasatch Advisors Inc. acquired a new position in shares of Semler Scientific in the 4th quarter worth approximately $10,898,000. 37.99% of the stock is currently owned by institutional investors and hedge funds.

其他幾家對衝基金也增持或減持了該業務的股份。第一季度,Nantahala Capital Management LLC將其在Semler Science的頭寸增加了27.9%。Nantahala Capital Management LLC現在擁有這家醫療設備提供商356,875股票,價值17,687,000美元,在此期間又購買了77,790股票。高盛股份有限公司在第一季度將其在賽姆勒科學公司的股票頭寸提高了49.7%。高盛股份有限公司在此期間又購買了75,574股,目前持有227,529股這家醫療設備供應商的股票,價值11,276,000美元。EVR Research LP在第一季度收購了Semler Science價值約991.2萬美元的新股票頭寸。阿瓦隆投資諮詢公司在第一季度將其在賽姆勒科學公司的股票頭寸提高了244.0%。在此期間,Avalon Investment&Consulting又購買了111,743股,現在擁有157,534股這家醫療設備提供商的股票,價值7,807,000美元。最後,Wasatch Advisors Inc.在第四季度收購了Semler Science價值約10,898,000美元的新股票頭寸。37.99%的股票目前由機構投資者和對衝基金持有。

Get
到達
Semler Scientific
塞姆勒科學
alerts:
警報:

Semler Scientific Stock Performance

賽姆勒科學股票表現

Shares of OTCMKTS SMLR opened at $39.69 on Tuesday. The company has a market capitalization of $269.93 million, a P/E ratio of 24.65 and a beta of 0.72. Semler Scientific, Inc. has a 52-week low of $27.02 and a 52-week high of $153.21. The company's 50 day moving average price is $38.93 and its 200-day moving average price is $38.35.

週二,OTCMKTS SMLR的股價開盤報39.69美元。該公司市值為2.6993億美元,市盈率為24.65倍,貝塔係數為0.72。Semler Science,Inc.的52周低點為27.02美元,52周高位為153.21美元。該公司的50日移動均線價格為38.93美元,200日移動均線價格為38.35美元。

Semler Scientific (OTCMKTS:SMLR – Get Rating) last issued its quarterly earnings results on Tuesday, August 2nd. The medical equipment provider reported $0.51 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.11. The firm had revenue of $14.83 million for the quarter, compared to the consensus estimate of $14.82 million. Semler Scientific had a net margin of 24.08% and a return on equity of 30.15%. Analysts forecast that Semler Scientific, Inc. will post 1.58 earnings per share for the current year.
賽姆勒科學公司(OTCMKTS:SMLR-GET Rating)最近一次發佈季度收益報告是在8月2日(星期二)。這家醫療設備供應商公佈本季度每股收益(EPS)為0.51美元,高於分析師普遍預期的0.40美元至0.11美元。該公司本季度營收為1483萬美元,而市場普遍預期為1482萬美元。賽姆勒科學公司的淨利潤率為24.08%,股本回報率為30.15%。分析師預測,賽姆勒科學公司本年度每股收益將達到1.58美元。

Semler Scientific Profile

塞姆勒科學畫像

(Get Rating)

(獲取評級)

Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Semler Science,Inc.提供技術解決方案,以提高美國醫療保健提供者的臨牀效果和效率。該公司的產品包括QuantaFlo,這是一種四分鐘的辦公室內血液流動測試,使醫療保健提供者能夠使用血流測量作為患者血管狀況檢查的一部分。

Featured Articles

專題文章

  • Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
  • Oracle's Short-Term Pain Could Be Your Long-Term Gain
  • Lucid is Looking Like a Clear EV Winner
  • Still Lovin' It: Investors Keep Visiting McDonald's
  • Did FedEx Just Deliver A Buying Opportunity?
  • Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
  • 免費獲取StockNews.com關於Semler Science(SMLR)的研究報告
  • 甲骨文的短期痛苦可能是你的長期收益
  • Lucid看起來像是電動汽車的贏家
  • 仍然愛着它:投資者繼續光顧麥當勞
  • 聯邦快遞剛剛提供了一個買入機會嗎?
  • 自動區重新進入拉力賽模式,新高在望

Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating).

想看看其他對衝基金持有SMLR的情況嗎?訪問HoldingsChannel.com獲取Semler Science,Inc.(OTCMKTS:SMLR-GET Rating)的最新13F文件和內幕交易。

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

接受《塞姆勒科技日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Semler Science及相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論